共 71 条
[1]
Ferlay J., Steliarova-Foucher E., Lortet-Tieulent J., Rosso S., Coebergh J.W., Comber H., Forman D., Bray F., Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012, Eur J Cancer, 49, pp. 1374-1403, (2013)
[2]
Torre L.A., Bray F., Siegel R.L., Ferlay J., Lortet-Tieulent J., Jemal A., Global cancer statistics, 2012, CA: Cancer J Clin, 65, pp. 87-108, (2015)
[3]
Galaal K., Bryant A., Fisher A.D., Al-Khaduri M., Kew F., Lopes A.D., Laparoscopy versus laparotomy for the management of early stage endometrial cancer, Cochrane Database Syst Rev, 9, (2012)
[4]
Janda M., Gebski V., Brand A., Hogg R., Jobling T.W., Land R., Manolitsas T., McCartney A., Nascimento M., Neesham D., Nicklin J.L., Oehler M.K., Otton G., Perrin L., Salfinger S., Hammond I., Leung Y., Walsh T., Sykes P., Ngan H., Garrett A., Laney M., Ng T.Y., Tam K., Chan K., Wrede C.D., Pather S., Simcock B., Farrell R., Obermair A., Quality of life after total laparoscopic hysterectomy versus total abdominal hysterectomy for stage I endometrial cancer (LACE): a randomised trial, Lancet Onc
[5]
Walker J.L., Piedmonte M.R., Spirtos N.M., Eisenkop S.M., Schlaerth J.B., Mannel R.S., Spiegel G., Barakat R., Pearl M.L., Sharma S.K., Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group Study LAP2, J Clin Oncol, 27, pp. 5331-5336, (2009)
[6]
Kroft J., Li Q., Saskin R., Elit L., Bernardini M.Q., Gien L.T., Trends over time in the use of laparoscopic hysterectomy for the treatment of endometrial cancer, Gynecol Oncol, 138, pp. 536-541, (2015)
[7]
Peplinski R., Past, present and future of the Da Vinci robot, (2006)
[8]
Herron D.M., Marohn M., Group S.-M.R.S.C., A consensus document on robotic surgery, Surg Endosc, 22, 2, pp. 313-325, (2008)
[9]
Mendivil A., Holloway R.W., Boggess J.F., Emergence of robotic assisted surgery in gynecologic oncology: American perspective, Gynecol Oncol, 114, pp. S24-S31, (2009)
[10]
Moher D., Liberati A., Tetzlaff J., Altman D.G., Group P., Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement, Open Med, 3, pp. e123-e130, (2009)